Fresenius Medical Care AGMEX:FME N 50 Net Margin % is 2.55% as of Mar. 2026, which is 58% below its 10-year median of 6.01. GuruFocus rates MEX:FME N with a GF Score™ of 50/100 and a GF Value™ of MXN1,677.25 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 60.78% on this metric.
The historical rank and industry rank for Fresenius Medical Care AG's Net Margin % or its related term are showing as below:
MEX:FME N'
s Net Margin % Range Over the Past 10 Years
Min: 2.57 Med: 6.01 Max: 11.98
Current: 4.88
MEX:FME N's Net Margin % is ranked better than 60.78% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs MEX:FME N: 4.88
Fresenius Medical Care AG (MEX:FME N) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Fresenius Medical Care AG Net Margin % Related Terms
Fresenius Medical Care AG Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:FME N vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (MEX:FME N) has a Net Margin % of 2.55% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Fresenius Medical Care AG and its competitors. This is 58% below median its historical median of 6.01. Over the past decade, Fresenius Medical Care AG's Net Margin % has ranged from 2.57 to 11.98. According to the industry distribution chart, Fresenius Medical Care AG ranks #262 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 39.2%.
Is Fresenius Medical Care AG's Net Margin % too high?
Fresenius Medical Care AG's current Net Margin % of 2.55% is 58% below median its 10-year median of 6.01. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 11.98. The Healthcare Providers & Services industry median Net Margin % is 2.89. Fresenius Medical Care AG's value of 2.55% is 11.6% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #262 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #262 out of 668 companies for Net Margin %. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median Net Margin % is 2.89. Fresenius Medical Care AG's value of 2.55% is 11.6% below this benchmark. Historically, Fresenius Medical Care AG's own Net Margin % has ranged from 2.57 to 11.98 over the past decade. While the company's 10-year median is 6.01 vs. the industry median of 2.89, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Net Margin % of 2.55% is 11.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Net Margin % is 2.55%, which is 58% below median its own 10-year median of 6.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,677.25, compared to a current price of MXN778.14 — trading 53.6% below its estimated fair value. The current Net Margin % is 2.55%, which is 58% below median its 10-year median of 6.01 and 11.6% below the Healthcare Providers & Services industry median of 2.89. Fresenius Medical Care AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current Net Margin % is 2.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of MXN778.14 is trading 53.6% below its estimated GF Value™ of MXN1,677.25.
GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.
Key valuation signals for MEX:FME N:
Net Margin %: 2.55% (58% below median its 10-year median of 6.01)
GF Value™: MXN1,677.25 vs. price of MXN778.14 (53.6% below fair value)
Industry Position: 11.6% below the Healthcare Providers & Services median (#262 of 668)
No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
50GF Score
Get the complete analysis for MEX:FME N
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FME N has been successfully added to your 
